GSK- Our contribution to the fight against novel coronavirus (COVID-19)
As a leader in science and innovation, we are helping to contribute to the fight against COVID-19 with one of our advanced vaccine adjuvant systems.
On 7 January 2020, a novel coronavirus (COVID-19) was identified as the cause of pneumonia cases in Wuhan City, Hubei Province of China. Additional cases have since been found in a number of countries, which so far can all be traced back to Wuhan City, China.
What are coronaviruses?
Coronaviruses are a family of viruses that can lead to respiratory illness, including Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). They are transmitted between animals and people and can evolve into strains not previously identified in humans.
This article was presented to you by GSK.